| References |
|
|
Akiyama TE,
Sakai S,
Lambert G et al.
(2002)
Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.
Molecular and Cellular Biology
22:
26072619.
|
|
|
Arnold L,
Henry A,
Poron F et al.
(2007)
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis.
Journal of Experimental Medicine
204:
10571069.
|
|
|
Beaumont C and
Delaby C
(2009)
Recycling iron in normal and pathological states.
Seminars in Hematology
46:
328338.
|
|
|
Brown MS and
Goldstein JL
(1986)
A receptor-mediated pathway for cholesterol homeostasis.
Science
232:
3447.
|
|
|
Castrillo A,
Joseph SB,
Vaidya SA et al.
(2003)
Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism.
Molecular Cell
12:
805816.
|
|
|
Chawla A,
Boisvert WA,
Lee CH et al.
(2001)
A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.
Molecular Cell
7:
161171.
|
|
|
Chinetti G,
Lestavel S,
Bocher V et al.
(2001)
PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.
Nature Medicine
7:
5358.
|
|
|
Cipollone F,
Cicolini G and
Bucci M
(2008)
Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives.
Pharmacology & Therapeutics
118:
161180.
|
|
|
Flannagan RS,
Cosio G and
Grinstein S
(2009)
Antimicrobial mechanisms of phagocytes and bacterial evasion strategies.
Nature Reviews. Microbiology
7:
355366.
|
|
|
Fojo SS and
Brewer HB
(1992)
Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II.
Journal of Internal Medicine
231:
669677.
|
|
|
Galkina E and
Ley K
(2007)
Vascular adhesion molecules in atherosclerosis.
Arteriosclerosis, Thrombosis, and Vascular Biology
27:
22922301.
|
|
|
Gautier EL,
Jakubzick C and
Randolph GJ
(2009)
Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis.
Arteriosclerosis, Thrombosis, and Vascular Biology
29:
14121418.
|
|
|
Geissmann F,
Jung S and
Littman DR
(2003)
Blood monocytes consist of two principal subsets with distinct migratory properties.
Immunity
19:
7182.
|
|
|
Ghisletti S,
Huang W,
Ogawa S et al.
(2007)
Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma.
Molecular Cell
25:
5770.
|
|
|
Glass C and
Witztum J
(2001)
Atherosclerosis: the road ahead.
Cell
104:
503516.
|
|
|
Haffner SM,
Greenberg AS,
Weston WM et al.
(2002)
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Circulation
106:
679684.
|
|
|
Hazen SL
(2008)
Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity.
Journal of Biological Chemistry
283:
1552715531.
|
|
|
Hume DA
(2008)
Macrophages as APC and the dendritic cell myth.
Journal of Immunology
181:
58295835.
|
|
|
Kim JB,
Wright HM,
Wright M and
Spiegelman BM
(1998)
ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand.
Proceedings of the National Academy of Sciences of the USA
95:
43334337.
|
|
|
Krey G,
Braissant O,
L'Horset F et al.
(1997)
Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
Molecular Endocrinology
11:
779791.
|
|
|
Li AC and
Palinski W
(2006)
Peroxisome proliferator-activated receptors: how their effects on macrophages can lead to the development of a new drug therapy against atherosclerosis.
Annual Review of Pharmacology and Toxicology
46:
139.
|
|
|
Lloberas J and
Celada A
(2009)
p21(waf1/CIP1), a CDK inhibitor and a negative feedback system that controls macrophage activation.
European Journal of Immunology
39:
691694.
|
|
|
Mak PA,
Laffitte BA,
Desrumaux C et al.
(2002)
Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta.
Journal of Biological Chemistry
277:
3190031908.
|
|
|
Martinez FO,
Helming L and
Gordon S
(2009)
Alternative activation of macrophages: an immunologic functional perspective.
Annual Review of Immunology
27:
451483.
|
|
|
Mayerl C,
Lukasser M,
Sedivy R et al.
(2006)
Atherosclerosis research from past to present: on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow.
Virchows Archiv
449:
96103.
|
|
|
Moore GB,
Pickavance LC,
Briscoe CP et al.
(2008)
Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expression.
Diabetes, Obesity & Metabolism
10:
251263.
|
|
|
Napoli C,
D'Armiento FP,
Mancini FP et al.
(1997)
Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.
Journal of Clinical Investigation
100:
26802690.
|
|
|
Noels H,
Bernhagen J and
Weber C
(2009)
Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis.
Trends in Cardiovascular Medicine
19:
7686.
|
|
|
Paidassi H,
Tacnet-Delorme P,
Arlaud GJ and
Frachet P
(2009)
How phagocytes track down and respond to apoptotic cells.
Critical Reviews in Immunology
29:
111130.
|
|
|
Pandey AK and
Sassetti CM
(2008)
Mycobacterial persistence requires the utilization of host cholesterol.
Proceedings of the National Academy of Sciences of the USA
105:
43764380.
|
|
|
Peyron P,
Vaubourgeix J,
Poquet Y et al.
(2008)
Foamy macrophages from tuberculous patients granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence.
PLoS Pathogens
4:
e1000204.
|
|
|
Portugal LR,
Fernandes LR,
Pietra Pedroso VS et al.
(2008)
Influence of low-density lipoprotein (LDL) receptor on lipid composition, inflammation and parasitism during Toxoplasma gondii infection.
Microbes and Infection
10:
276284.
|
|
|
Repa JJ,
Liang G,
Ou J et al.
(2000)
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.
Genes & Development
14:
28192830.
|
|
|
Repa JJ and
Mangelsdorf DJ
(2000)
The role of orphan nuclear receptors in the regulation of cholesterol homeostasis.
Annual Review of Cell and Developmental Biology
16:
459481.
|
|
|
Rhoades E,
Hsu F,
Torrelles JB et al.
(2003)
Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG.
Molecular Microbiology
48:
875888.
|
|
|
Ricote M,
Valledor AF and
Glass CK
(2004)
Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.
Arteriosclerosis, Thrombosis, and Vascular Biology
24:
230239.
|
|
|
Robins SJ,
Collins D,
Wittes JT et al.
(2001)
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.
Journal of the American Medical Association
285:
15851591.
|
|
|
Saha P,
Modarai B,
Humphries J et al.
(2009)
The monocyte/macrophage as a therapeutic target in atherosclerosis.
Current Opinion in Pharmacology
9:
109118.
|
|
|
Tabas I
(2002)
Consequences of cellular cholesterol accumulation: basic concepts and physiological implications.
Journal of Clinical Investigation
110:
905911.
|
|
|
Takahashi K,
Kimura Y,
Nagata K et al.
(2005)
ABC proteins: key molecules for lipid homeostasis.
Medical Molecular Morphology
38:
212.
|
|
|
Tangirala RK,
Bischoff ED,
Joseph SB et al.
(2002)
Identification of macrophage liver X receptors as inhibitors of atherosclerosis.
Proceedings of the National Academy of Sciences of the USA
99:
1189611901.
|
|
|
Wagner BL,
Valledor AF,
Shao G et al.
(2003)
Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression.
Molecular and Cellular Biology
23:
57805789.
|
|
|
Welch JS,
Ricote M,
Akiyama TE,
Gonzalez FJ and
Glass CK
(2003)
PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.
Proceedings of the National Academy of Sciences of the USA
100:
67126717.
|
|
|
Xaus J,
Comalada M,
Valledor AF et al.
(2001)
Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis.
Immunobiology
204:
543550.
|
|
|
Yona S and
Jung S
(2010)
Monocytes: subsets, origins, fates and functions.
Current Opinion in Hematology
17:
5359.
|
|
|
Zelcer N,
Hong C,
Boyadjian R and
Tontonoz P
(2009)
LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.
Science
325:
100104.
|
| Further Reading |
|
|
Chinetti-Gbaguidi G and
Staels B
(2009)
Lipid ligand-activated transcription factors regulating lipid storage and release in human macrophages.
Biochimica et Biophysica Acta
1791:
486493.
|
|
|
Galkina E and
Ley K
(2009)
Immune and inflammatory mechanisms of atherosclerosis.
Annual Review of Immunology
27:
165197.
|
|
|
Greaves DR and
Gordon S
(2009)
The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges.
Journal of Lipid Research
50(suppl.):
S282S286.
|
|
|
Korbel DS,
Schneider BE and
Schaible UE
(2008)
Innate immunity in tuberculosis: myths and truth.
Microbes and Infection
10:
9951004.
|
|
|
McLaren JE and
Ramji DP
(2009)
Interferon gamma: a master regulator of atherosclerosis.
Cytokine & Growth Factor Reviews
20:
125135.
|
|
|
Russell DG,
Cardona PJ,
Kim MJ,
Allain S and
Altare F
(2009)
Foamy macrophages and the progression of the human tuberculosis granuloma.
Nature Immunology
10:
943948.
|
|
|
Silverstein RL
(2009)
Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36.
Cleveland Clinic Journal of Medicine
76(suppl. 2):
S2730.
|